MERANTE BOSCHIN, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.236
EU - Europa 985
AS - Asia 437
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 7.666
Nazione #
US - Stati Uniti d'America 6.232
IT - Italia 380
CN - Cina 366
FI - Finlandia 163
SE - Svezia 155
DE - Germania 107
UA - Ucraina 102
VN - Vietnam 58
GB - Regno Unito 35
IE - Irlanda 15
FR - Francia 8
ES - Italia 5
IN - India 4
JP - Giappone 4
CA - Canada 3
CZ - Repubblica Ceca 3
NL - Olanda 3
PE - Perù 3
DK - Danimarca 2
EU - Europa 2
HK - Hong Kong 2
RU - Federazione Russa 2
SG - Singapore 2
AM - Armenia 1
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
Totale 7.666
Città #
Fairfield 970
Woodbridge 726
Houston 514
Chandler 509
Jacksonville 492
Ann Arbor 464
Ashburn 398
Wilmington 355
Seattle 347
Cambridge 326
Princeton 160
Beijing 120
Des Moines 88
San Diego 87
Helsinki 65
Padova 65
Nanjing 63
Medford 62
Dong Ket 58
Roxbury 58
Boardman 34
Milan 24
New York 23
Salerno 23
Hebei 21
Norwalk 21
Shenyang 20
Jiaxing 18
Guangzhou 16
Dublin 15
Nanchang 15
Columbus 14
Rome 13
Changsha 12
Redwood City 12
Florence 11
Naples 11
Cagliari 9
London 9
Ogden 9
Zhengzhou 8
Chicago 7
Falls Church 7
Jinan 7
Tianjin 6
Bologna 5
Indiana 5
Kharkiv 5
Los Angeles 5
Palermo 5
Kirkland 4
Munich 4
Redmond 4
Rockville 4
Taizhou 4
Borås 3
Casier 3
Castelbellino 3
Castellabate 3
Detroit 3
Dogliani 3
Fuzhou 3
Hefei 3
Hounslow 3
Kilburn 3
Legnaro 3
Mestre 3
Orange 3
San Francisco 3
Sassari 3
Tappahannock 3
Turin 3
Verona 3
Vicenza 3
Caponago 2
Catania 2
Catanzaro 2
Cervere 2
Düsseldorf 2
Faenza 2
Ferrara 2
Frederiksberg 2
Genoa 2
Gravina di Catania 2
Hnevotin 2
Hong Kong 2
Imperia 2
Kunming 2
Lanuvio 2
Lucca 2
Mesagne 2
Nuremberg 2
Perugia 2
Pescara 2
Portland 2
Portogruaro 2
Positano 2
Rimini 2
Rovescala 2
San Calogero 2
Totale 6.446
Nome #
MUTAZIONI BRAF NEL CARCINOMA PAPILLARE DELLA TIROIDE 218
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 185
FDG-PET/ct and parathyroid carcinoma. Review of literature and illustrative case series 174
Papillary thyroid microcarcinoma (PTMC: prognostic factors management and outcome in 403 patients. 148
Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. 143
Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAFV600E: A non-invasive tool panel for early detection of thyroid cancer 143
Thyroidectomy and parathyroid hormone: tracing hypocalcemia-prone patients. 139
Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. 129
The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors 123
Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits 122
Sentinel node mapping and biopsy in thyroid cancer a surgical perspective. 120
MEN2A/FMTC AND THE V804M RET MUTATION 112
Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. 112
Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics 111
RE : ANATOMIC CONFIGURATIONS OF THE RECURRENT LARYNGEAL NERVE AND INFERIOR THYROID ARTERY. 110
Laparoscopic adrenalectomy for pheochromocytoma: is it really more difficult? 105
Characterization of a novel complex BRAF mutation in a follicular variant papillary thyroid carcinoma 104
IGF-I influences everolimus activity in medullary thyroid carcinoma 104
Factors influencing the rising rates of adrenal surgery: analysis of a 25-year experience 103
Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. 102
Does the ultrasound dissector improve parathyroid gland preservation during surgery? 102
Rapid intraoperative parathyroid hormone assay in fine needle aspiration for differential diagnosis in thyroid and parathyroid surgery. 102
99Tc Nanocolloid sentinel node procedure in thyroid carcinoma 97
Papillary thyroid carcinoma: factors influencing recurrence and survival. 96
Complications in thyroid surgery for carcinoma: one institution's surgical experience. 95
Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? 94
Lymphoscintigraphy in differentiated thyroid cancer 94
99Tc Nanocolloid sentinel node procedure in thyroid carcinoma 93
Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 93
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 93
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 92
Clinical presentation and management of acromegaly in elderly patients 92
Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? 90
Familial nonsyndromic pheochromocytoma. 89
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 89
Specifying the molecular pattern of sporadic parathyroid tumorigenesis - €”The Y282D variant of the GCM2 gene 89
Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience 86
Stony heart and severe hyperparathyroidism. 86
Head and neck surgery in obese patients 85
Aberrant right subclavian artery ("arteria lusoria") without the known associated nerve anomaly: an "€œanomaly of the anomaly"€? A clinical case and review of the literature 85
Locally advanced differentiated thyroid carcinoma: a 35-year mono-institutional experience in 280 patients. 82
Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions. 80
Complications in thyroid resurgery: a single institutional experience on 233 patients from a whole series of 4.752 homogeneously treated patients. 80
Contribution of SLN investigaton with 99mTc-nanocolloid in clinical staging of thyroid cancer: ttechnical feasibility. 79
Pariectomia toracica e tiroidectomia totale sincrone per carcinoma follicolare della tiroide plurimetastatico: il razionale. 79
Estrogen and thyroid cancer is a stem affair: A preliminary study 76
Locally advanced differentiated thyroid carcinoma: a 35-year mono-institutional experience in 280 patients. 74
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. 74
A very rare bilateral adrenal tumor. 74
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study 74
99mTc nanocolloidal sentinel node lymphoscintigraphy and biopsy in differentiated thyroid carcinoma. 72
Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period 72
Thyroid microcarcinoma: an elusive malignant disease. 71
Natural history , diagnosis, treatmente and outcome of medullary thyroid cancer: 37 yars experience on 157 patients. 69
The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma. 67
Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare Tumor 67
Complications in thyroid surgery for carcinoma: one institution's surgical experience 64
Neck emergency due to parathyroid adenoma bleeding a case report. 63
The Zuckerkandl tubercle 61
Paragangliomi addominali extrasurrenalici 61
Capitolo: Radioguided sentinel lymph node mapping and biopsy in thyroid cancer 59
Differentiated thyroid carcinoma in childhood: a monoinstitutional experience 58
Pancreatic mucinous cystic tumor in Turner syndrome: How a tumor bends to a genetic disease. 55
A "pilot light" of the right non-recurrent laryngeal nerve. 54
Carcinoma differenziato della tiroide (CDT) dopo il primo intervento: ruolo della scintigrafia MIBI e chirurgia radioguidata. 53
Advanced Medullary thyroid carcinoma: results of treatment in 35 patinets and crrelation to FDG PET-CT and 111 in Octotride imaging 53
Attualità diagnostiche e terapeutiche nella patologia benigna della tiroide 52
Can we avoid inadvertend parathyroidectomy during thyroid surgery? 51
RADIO-GUIDED PARATHYROIDECTOMY. A PROSPECTIVE STUDY IN 54 PATIENTS WITH PRIMARY HYPERPARATHYROIDISM 50
Metastasi polmonare isolata di carcinoma paratiroideo. 49
Sentinel lymp node (SLN) procedure with patye in 153 patients withs papillary thyroid carcinoma (PTC): is it an accurate staging method? 49
Thyroid intrafollicular neoplasia (TIN) as a precursor of papillary microcarcinoma. 48
Factors influencing the rising rates of adrenal surgery: analysis of 25 years experience. 48
Surgical therapeutic planning options in nodular goiter 47
Treatment and 35 year-outcome of papillary thyroid carcinoma: monoinstitutional experience. 46
Carcinoma localmente avanzato della tiroide: prognosi a distanza. 45
Carcinoma differenziato della tiroide dopo il primo intervento: ruolo della scintigrafia MIBI e chirurgia radioguidata 44
Surgical treatment of primary hyperparathyroidism: from bilateral neck exploration to minimally invasive surgery 43
Sentinel lymph node procedure in thyroid carcinoma patients. Our experience. 43
PAPILLARY THYROID CARCINOMA: 35-YEAR OUTCOME AND PROGNOSIC FACTORS IN A GROUP OF 1858 PATIENTS 42
An unexpected anomalous branch from the cervical vagus looping to the recurrent laryngeal. 42
Natural history, diagnosis, treatment and outcome of medullary thyroid carcinoma: 37-years experience. 39
Nonrecurrent and ipsilateral recurrent inferior laryngeal nerves. 38
99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients. 38
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications 36
Tumori differenziati della tiroide negli ultrasettantenni 35
Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study 35
Sentinel node mapping and biopsy in clinical staging of thyroid cancer: technical procedure and surgical perspective. 34
THE SENTINEL NODE PROCEDURE WITH PATENT BLUE V DYE IN THE SURGICAL TREATMENT OF PAPILLARY THYROID CARCINOMA 34
99mTc nanocolloid sentinel node procedure in thyroid carcinoma 33
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 33
Diagnosis treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma 32
Sentinel node lymphoscintigraphy and biopsy in differentiated thyroid cancer 32
PARATHYROIDECTOMY. A PROSPECTIVE STUDY IN 54 PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. 32
Management strategies in thyroid lymphoma. 31
Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with pubished data. 30
Enucleation of deep adenomas with cavitron ultrasonic surgical aspiration (Cusa) 29
Cosa c'è di nuovo su: linfonodo sentinella in chirurgia oncologica tiroidea. 28
Rottura in due tempi di adenoma paratiroideo misconosciuto. 26
Laparoscopic adrenaletomy for incidentaloma:a single institution retrospective study 26
Totale 7.540
Categoria #
all - tutte 24.900
article - articoli 21.215
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 669
Totale 46.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019376 0 0 0 0 0 0 0 0 0 0 190 186
2019/20201.880 245 88 106 322 156 127 127 188 169 178 100 74
2020/20211.046 68 88 65 98 43 78 37 115 158 94 102 100
2021/20221.375 32 194 154 96 86 81 91 134 41 39 166 261
2022/20231.143 228 117 18 136 191 169 12 73 124 14 52 9
2023/2024485 24 64 100 49 42 40 70 51 26 17 2 0
Totale 7.730